Onward Medical N.V. Total Assets
Onward Medical N.V. total assets. Based on the latest financial reports, Onward Medical N.V. (ONWD) holds total assets worth €84.55 Million EUR (≈ $98.85 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Onward Medical N.V. stock valuation for the company's overall valuation and market capitalisation.
Total Assets of Onward Medical N.V. (2017–2025)
Total assets of Onward Medical N.V. from 2017 to 2025. This chart illustrates how Onward Medical N.V.'s total assets have evolved over time, based on quarterly financial data. See current stock price of Onward Medical N.V. for real-time trading data and today's change.
Onward Medical N.V. - Asset Composition Analysis
Onward Medical N.V. Total Assets Breakdown (December 2025)
Onward Medical N.V. total assets breakdown as of December 2025. Onward Medical N.V.'s total assets of €84.55 Million consist of 87.6% current assets and 12.4% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 80.6% |
| Accounts Receivable | €1.20 Million | 1.4% |
| Inventory | €803.00K | 1.0% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €7.00 Million | 8.3% |
| Goodwill | €1.74 Million | 2.1% |
Asset Composition Trend (2017–2025)
This chart illustrates how Onward Medical N.V.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore Onward Medical N.V. (ONWD) working capital ratio to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Onward Medical N.V.'s current assets represent 87.6% of total assets in 2025, a decrease from 91.5% in 2017.
- Cash Position: Cash and equivalents constituted 80.6% of total assets in 2025, down from 88.9% in 2017.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 10.0% of total assets, an increase from 0.0% in 2017.
- Asset Diversification: The largest asset category is intangible assets at 8.3% of total assets.
Onward Medical N.V. Competitors by Total Assets
Key competitors of Onward Medical N.V. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Hyloris Developmentsen Sa
BR:HYL
|
Belgium | €37.05 Million |
|
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
|
USA | $11.72 Billion |
|
Oruka Therapeutics, Inc.
NASDAQ:ORKA
|
USA | $1.14 Billion |
|
Gempharmatech Co. Ltd. A
SHG:688046
|
China | CN¥2.80 Billion |
|
Vor Biopharma Inc
NASDAQ:VOR
|
USA | $481.05 Million |
|
Inventiva S.A
PA:IVA
|
France | €249.51 Million |
|
Sunmax Biotechnology Co Ltd
TWO:4728
|
Taiwan | NT$1.90 Billion |
|
Apnimed, Inc. Common Stock
NASDAQ:APMD
|
USA | $342.63 Million |
Onward Medical N.V. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 6.67 | 6.85 | 2.61 |
| Quick Ratio | 6.60 | 6.84 | 2.61 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €62.98 Million | €54.33 Million | €4.30 Million |
Onward Medical N.V. - Advanced Valuation Insights
This section examines the relationship between Onward Medical N.V.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.54 |
| Latest Market Cap to Assets Ratio | 1.82 |
| Asset Growth Rate (YoY) | 8.7% |
| Total Assets | €84.55 Million |
| Market Capitalization | $153.63 Million USD |
Valuation Analysis
Above Book Valuation: The market values Onward Medical N.V.'s assets above their book value (1.82x), reflecting positive investor sentiment about the company's future prospects.
Positive Asset Growth: Onward Medical N.V.'s assets grew by 8.7% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Onward Medical N.V. (2017–2025)
The table below shows the annual total assets of Onward Medical N.V. from 2017 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | €84.55 Million ≈ $98.85 Million |
+8.72% |
| 2024-12-31 | €77.77 Million ≈ $90.92 Million |
+78.25% |
| 2023-12-31 | €43.63 Million ≈ $51.01 Million |
-43.04% |
| 2022-12-31 | €76.59 Million ≈ $89.55 Million |
-26.91% |
| 2021-12-31 | €104.80 Million ≈ $122.52 Million |
+638.52% |
| 2020-12-31 | €14.19 Million ≈ $16.59 Million |
-39.22% |
| 2019-12-31 | €23.34 Million ≈ $27.29 Million |
+144.19% |
| 2018-12-31 | €9.56 Million ≈ $11.18 Million |
+16.83% |
| 2017-12-31 | €8.18 Million ≈ $9.57 Million |
-- |
About Onward Medical N.V.
Onward Medical N.V., a medical technology company, develops and commercializes therapies to enable functional recovery for people with Spinal Cord Injury (SCI). The company engages in developing ARCEX, a technology to enhance hand strength and sensation for individuals with SCI; ARCIM, a spinal cord stimulation system designed to address blood pressure instability and other symptoms in people wit… Read more